Qbiotics, page-206

First 206 Last

Share
Profile

Follow
paperclip

2,444 Posts.

02/03/21

16:32

Post #: 51458607
Share

Originally posted by Rajenp5: ↑

Published in 2019 I think but hadnt seen some of the pics post treatment with TT of the 4 patients who had complete response. Startling to say the least, particularly the melanoma and facial angiosarcoma, underlining the potential of TT in the human field. Saved patient from a total rhinectomy and left him disease free.

https://www.sciencedirect.com/science/article/pii/S2352396419307868

Fig. 3. Patient 102 Tumor response: Four melanomas of the right arm. The estimated tumor volume treated was 100% for tumors 1 and 3 and 76% for tumor 2; tumor 4 was not treated. All target tumors had length, width, depth and volume of zero at Days 22, 29 and 36. The figure shows the progression from immediately pre-injection and 5, 8, and 22 days post-injection.

Patient 404 Tumor response: Melanoma of the axilla. The figure shows the progression from immediately pre-injection and 2, 8, and 29 days post-injection. The patient was assessed as a complete response through 33 months with an anenestic response, followed by systemic metastases.

Patient 406 Tumor response: An atypical fibroxanthoma of the leg and experienced stable disease. The figure shows the progression from immediately pre-injection, at 2, and 22 days post-injection, and at final assessment at 7 months.

Patient 407 Tumor response: An angiosarcoma of the nose with a recommendation for total rhinectomy. The figure shows the progression from immediately pre-injection and 2, 15, and 43 days post-injection. The patient was assessed as a complete response and remains clinically disease free 30.5 months post-injection.

Expand

very hard to believe this wont get through to a successful human cancer treatment, surely to god .
Upvote

Reply

Top Stories

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

There are more pages in this discussion • 1,048 more messages in this thread...

First 206 Last

Qbiotics, page-206

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Featured News

Featured News

Qbiotics, page-206

Top Stories

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Featured News

Featured News